DNA Namai - Company finances
|
EUR
|
2021
From: 2021-04-20
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 3,900 | 17,781 | 29,156 | 30,931 | 44,797 |
| Profit before tax | -4,807 | 4,592 | 15,020 | 8,253 | 13,231 |
| Net profit | -4,807 | 4,592 | 14,269 | 7,816 | 12,570 |
| Equity | -4,807 | -164 | 12,054 | 19,870 | 32,440 |
| Liabilities | - | 10,543 | 9,800 | 9,029 | 6,643 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 734 | 10,379 | 21,854 | 28,899 | 39,083 |
| Total assets | 734 | 10,379 | 21,854 | 28,899 | 39,083 |
|
Taxes paid
|
|||||
| STI taxes | - | - | - | 751 | 197 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +355.9% | +64.0% | +6.1% | +44.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -654.9% | 44.2% | 65.3% | 27.0% | 32.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 118.4% | 39.3% | 38.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -123.3% | 25.8% | 48.9% | 25.3% | 28.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -123.3% | 25.8% | 51.5% | 26.7% | 29.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.8 | 0.5 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
DNA Namai - Social security debts
The company had no debts to Sodra
DNA Namai - VMI tax arrears
As of 2026-10-07, the amount of overdue STI tax debt of the company DNA Namai is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-07-01 | 2026-10-07 | 0.42 |
| 2025-07-01 | 2025-11-21 | 0.05 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
DNA Namai, MB (code 305739005) is a Lithuanian small partnership engaged in architectural activities. In 2025, the company generated revenue of €44.8K, up 44.8% year on year and 53.6% above 2023. Net profit reached €12.6K, compared with €7.8K in 2024 and €14.3K in 2023, while the 2025 profit margin stood at 28.1%. The three-year trend points to consistent revenue expansion, a weaker profitability level in 2024, and a recovery in 2025.
The balance sheet also improved over the period. Total assets increased to €39.1K in 2025 from €28.9K in 2024 and €21.9K in 2023. Equity rose to €32.4K, while liabilities decreased to €6.6K. This resulted in an equity ratio of 83.0% and a debt-to-equity ratio of 0.20. Asset turnover was 1.15x, ROE was 38.8%, and ROA was 32.2% in 2025, indicating strong profitability and efficient use of a relatively small asset base.
The balance sheet also improved over the period. Total assets increased to €39.1K in 2025 from €28.9K in 2024 and €21.9K in 2023. Equity rose to €32.4K, while liabilities decreased to €6.6K. This resulted in an equity ratio of 83.0% and a debt-to-equity ratio of 0.20. Asset turnover was 1.15x, ROE was 38.8%, and ROA was 32.2% in 2025, indicating strong profitability and efficient use of a relatively small asset base.